Commentary on: The optimal Dose of Ribavirin for Chronic Hepatitis C: From Literature Evidence to Clinical Practice.
作者信息
El-Shabrawi Mortada, Isa Mona
机构信息
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
出版信息
Hepat Mon. 2013 Feb 28;13(2):e7867. doi: 10.5812/hepatmon.7867. Print 2013 Feb.
Abstract
摘要
相似文献
1
Commentary on: The optimal Dose of Ribavirin for Chronic Hepatitis C: From Literature Evidence to Clinical Practice.关于《慢性丙型肝炎的最佳利巴韦林剂量：从文献证据到临床实践》的述评
Hepat Mon. 2013 Feb 28;13(2):e7867. doi: 10.5812/hepatmon.7867. Print 2013 Feb.
2
3
[Treatment of chronic hepatitis C in patients without previous treatment].
Rev Gastroenterol Mex. 2002 Oct;67 Suppl 2:S42-4.
4
Ribavirin plus interferon versus interferon for chronic hepatitis C.利巴韦林联合干扰素与单用干扰素治疗慢性丙型肝炎的比较
Cochrane Database Syst Rev. 2010 Jan 20(1):CD005445. doi: 10.1002/14651858.CD005445.pub2.
5
Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy.
Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1207-12. doi: 10.1097/00042737-200411000-00020.
6
Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.干扰素和利巴韦林治疗慢性丙型肝炎患者血液学异常的预测因素。
Ann Hematol. 2010 Feb;89(2):121-5. doi: 10.1007/s00277-009-0774-y. Epub 2009 Jun 30.
7
[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C].[与干扰素和利巴韦林治疗慢性丙型肝炎相关的克罗恩病]
Gastroenterol Clin Biol. 2005 Feb;29(2):193-6. doi: 10.1016/s0399-8320(05)80736-5.
8
Characteristics of hepatitis C treatment with pegylated interferons and ribavirin.聚乙二醇干扰素和利巴韦林治疗丙型肝炎的特点。
Ann Hepatol. 2010;9 Suppl:61-4.
9
Combination treatment with interferon and ribavirin for chronic hepatitis C.干扰素与利巴韦林联合治疗慢性丙型肝炎。
Clin Liver Dis. 1999 Nov;3(4):811-26. doi: 10.1016/s1089-3261(05)70240-3.
本文引用的文献
1
2
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.聚乙二醇干扰素 alfa-2a 联合利巴韦林治疗儿童和青少年慢性丙型肝炎病毒感染。
J Hepatol. 2010 Jun;52(6):827-31. doi: 10.1016/j.jhep.2010.01.028. Epub 2010 Mar 15.
3
4
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.儿童慢性丙型肝炎患者接受聚乙二醇干扰素 alfa-2b 联合利巴韦林治疗的高持续病毒学应答率。
J Hepatol. 2010 Apr;52(4):501-7. doi: 10.1016/j.jhep.2010.01.016. Epub 2010 Feb 4.
5
Managing pediatric hepatitis C: current and emerging treatment options.管理小儿丙型肝炎：当前和新兴的治疗选择。
Ther Clin Risk Manag. 2009 Jun;5(3):651-60. doi: 10.2147/tcrm.s5078. Epub 2009 Aug 20.
6
Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?在2/3型慢性丙型肝炎中，聚乙二醇化干扰素联合利巴韦林是否优于普通干扰素？
World J Gastroenterol. 2008 Nov 21;14(43):6627-31. doi: 10.3748/wjg.14.6627.
7
Ribavirin in the treatment of hepatitis C.利巴韦林治疗丙型肝炎
Anticancer Res. 2005 Mar-Apr;25(2B):1315-20.
8
Is there a correlation between degree of viremia and liver histology in chronic hepatitis C?慢性丙型肝炎患者的病毒血症程度与肝脏组织学之间是否存在相关性？
J Pak Med Assoc. 2004 Sep;54(9):476-9.
9
Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration.
Cleve Clin J Med. 2004 May;71 Suppl 3:S8-12. doi: 10.3949/ccjm.71.suppl_3.s8.
10
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.聚乙二醇干扰素α-2b联合利巴韦林用于治疗既往未接受治疗的丙型肝炎病毒2型或3型感染的慢性丙型肝炎患者。
J Hepatol. 2004 Jun;40(6):993-9. doi: 10.1016/j.jhep.2004.02.007.
Zotero 插件